BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 96 filers reported holding BIOSCRIP INC in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $47,000 | -93.2% | 15,237 | -93.6% | 0.00% | -91.2% |
Q2 2018 | $692,000 | -21.4% | 236,294 | -34.0% | 0.03% | -27.7% |
Q1 2018 | $880,000 | +18.9% | 357,806 | +40.7% | 0.05% | +4.4% |
Q4 2017 | $740,000 | -13.7% | 254,306 | -18.4% | 0.04% | -22.4% |
Q3 2017 | $857,000 | +4661.1% | 311,500 | +2811.2% | 0.06% | +5700.0% |
Q1 2017 | $18,000 | -30.8% | 10,700 | -56.7% | 0.00% | -50.0% |
Q4 2016 | $26,000 | -87.8% | 24,700 | +2.0% | 0.00% | -88.2% |
Q3 2013 | $213,000 | -9.4% | 24,219 | +69.9% | 0.02% | -39.3% |
Q2 2013 | $235,000 | – | 14,255 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |